Related Experiment Video

Updated: Jun 23, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus

Seiji Baba1, Yasuhiro Yamada, Yuichiro Hatano

  • 1Department of Tumor Pathology, Gifu University School of Medicine, Gifu, Japan.

Cancer Science
|May 13, 2009
PubMed

Insights

Reducing DNA methylation (hypomethylation) suppressed squamous cell carcinoma development in mouse tongues and esophagi. This suggests epigenetic modifications could aid in preventing and treating upper digestive tract cancers.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Genome-wide DNA hypomethylation and site-specific hypermethylation are common in human cancers.
  • Reduced DNA methylation has variable effects on tumor development, depending on cell type and cancer stage.

Purpose of the Study:

  • To investigate the impact of DNA hypomethylation on squamous carcinogenesis in the tongue and esophagus.
  • To assess the role of DNA methyltransferase 1 (Dnmt1) in this process.

Main Methods:

  • Utilized DNA methyltransferase 1 (Dnmt1) hypomorphic alleles to genetically reduce genomic methylation levels in mice.
  • Induced squamous carcinogenesis using 4-nitroquinoline 1-oxide in the tongue and esophagus.
  • Performed histological analyses to evaluate tumor development and type.

Main Results:

  • Genetic reduction of DNA methylation significantly suppressed tumor formation in both the tongue and esophagus.
  • DNA hypomethylation preferentially inhibited the development of squamous cell carcinomas.
  • The findings indicate a protective role of hypomethylation against squamous carcinogenesis in these tissues.

Conclusions:

  • Genomic hypomethylation inhibits squamous carcinogenesis in the tongue and esophagus.
  • Pharmacological manipulation of epigenetic status may offer a strategy for preventing and treating upper digestive tract cancers.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...